VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
GNFTGenfit S.A.
$8.95$448M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. GNFT
  3. Financial Ratios

Genfit S.A. (GNFT) Financial Ratios

21 years of historical data (2004–2024) · Healthcare · Biotechnology

View Quarterly Ratios →

P/E Ratio
↑
256.88
↑+301% vs avg
5yr avg: 64.03
0100%ile100
30Y Low4.1·High124.0
View P/E History →
EV/EBITDA
↑
73.07
↑+305% vs avg
5yr avg: 18.06
0100%ile100
30Y Low2.7·High33.4
P/FCF
↑
27.10
↑+240% vs avg
5yr avg: 7.97
0100%ile100
30Y Low2.8·High13.1
P/B Ratio
↑
5.59
↑+120% vs avg
5yr avg: 2.54
080%ile100
30Y Low2.3·High8.8
ROE
↑
2.2%
↓+105% vs avg
5yr avg: -44.6%
086%ile100
30Y Low-298%·High131%
Debt/EBITDA
↑
12.41
↑+70% vs avg
5yr avg: 7.28
0100%ile100
30Y Low2.1·High12.4

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

GNFT Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

Genfit S.A. trades at 256.9x earnings, 301% above its 5-year average of 64.0x, sitting at the 100th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 1061%. On a free-cash-flow basis, the stock trades at 27.1x P/FCF, 240% above the 5-year average of 8.0x.

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Market Cap$448M$187M$191M$218M$278M$187M$736M————
Enterprise Value$425M$167M$184M$157M$94M$201M$643M————
P/E Ratio →256.88124.00——4.07——————
P/S Ratio5.752.796.7010.803.47243.8223.87————
P/B Ratio5.592.702.822.312.33—8.76————
P/FCF27.1013.14——2.80——————
P/OCF25.3512.29——2.78——————

P/E links to full P/E history page with 30-year chart

GNFT EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

Genfit S.A.'s enterprise value stands at 73.1x EBITDA, 305% above its 5-year average of 18.1x. The Healthcare sector median is 14.2x, placing the stock at a 414% premium on an enterprise-value basis.

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
EV / Revenue—2.506.437.791.17262.9820.85————
EV / EBITDA73.0733.41——2.71——————
EV / EBIT111.4625.25——2.91——————
EV / FCF—11.76——0.94——————

GNFT Profitability

Margins and return-on-capital ratios measuring operating efficiency

Genfit S.A. earns an operating margin of 4.9%. Operating margins have expanded from -135.1% to 4.9% over the past 3 years, signaling improving operational efficiency. ROE of 2.2% is modest. ROIC of 4.5% represents below-average returns on invested capital.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Gross Margin99.6%99.6%98.8%98.8%99.8%73.6%99.4%-2587.0%-1789.0%-598.9%-266.4%
Operating Margin4.9%4.9%-93.1%-135.1%39.7%-10836.2%-187.5%-100701.4%-48046.6%-12027.5%-3354.1%
Net Profit Margin2.2%2.2%-101.2%-117.5%84.0%-13231.5%-211.2%-115247.8%-49664.4%-11854.6%-3251.4%

Return on Capital

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
ROE2.2%2.2%-35.6%-22.2%130.7%-298.1%-124.1%-127.1%-47.4%-34.0%-27.2%
ROA0.9%0.9%-14.8%-9.5%28.0%-39.8%-24.2%-30.4%-25.5%-28.6%-22.0%
ROIC4.5%4.5%-42.4%-60.5%——————-1305.9%
ROCE3.1%3.1%-17.1%-13.8%16.5%-38.2%-25.3%-30.5%-27.3%-32.6%-25.9%

GNFT Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

Genfit S.A. carries a Debt/EBITDA ratio of 12.4x, which is highly leveraged (285% above the sector average of 3.2x). The company holds a net cash position — cash of $82M exceeds total debt of $62M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns. Interest coverage of just 1.4x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Debt / Equity0.900.901.030.800.62—2.188.101.570.040.10
Debt / EBITDA12.4112.41——2.15——————
Net Debt / Equity—-0.28-0.11-0.64-1.55—-1.11-1.80-1.06-1.02-0.98
Net Debt / EBITDA-3.93-3.93——-5.34——————
Debt / FCF—-1.38——-1.86——————
Interest Coverage1.381.38-5.14-6.276.49-6.50-4.74-6.33-24.31-277.71—

Net cash position: cash ($82M) exceeds total debt ($62M)

GNFT Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

A current ratio of 1.23x means Genfit S.A. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 4.02x to 1.23x over the past 3 years.

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Current Ratio1.231.232.944.024.275.956.685.5610.469.227.75
Quick Ratio1.231.232.944.024.275.956.685.5610.469.227.75
Cash Ratio1.091.092.023.574.125.516.365.2810.108.676.98
Asset Turnover—0.440.160.090.280.000.100.000.000.000.01
Inventory Turnover75.0075.0085.2562.0040.2550.5044.25463.50557.25141.7968.96
Days Sales Outstanding—41.21417.93287.4832.995686.84142.432089.491289.8710788.064160.45

GNFT Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Genfit S.A. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 0.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Earnings Yield0.4%0.8%——24.6%——————
FCF Yield3.7%7.6%——35.7%——————
Buyback Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%————
Total Shareholder Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%————
Shares Outstanding—$50M$50M$50M$56M$39M$37M$31M$31M$27M$25M

Peer Comparison

Compare GNFT with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
GNFT logoGNFTYou$448M256.973.127.199.6%4.9%2.2%4.5%12.4
MDGL logoMDGL$12B-39.9——94.1%-31.3%-42.5%-29.4%—
AKRO logoAKRO$4B-14.6————-39.2%-55.3%—
HALO logoHALO$8B26.911.312.778.1%58.4%153.6%32.1%2.4
ELVN logoELVN$3B-25.1————-27.0%-32.8%—
ALDX logoALDX$124M-3.7————-58.7%-245.8%—
CRNX logoCRNX$4B-7.1——86.0%-6714.8%-40.2%-37.8%—
ARWR logoARWR$12B-6721.395.673.6100.0%11.9%-0.5%9.3%3.0
ALNY logoALNY$38B122.967.982.181.8%13.5%73.3%33.4%2.3
VKTX logoVKTX$4B-10.1————-47.3%-44.4%—
LLY logoLLY$1.0T48.134.5116.283.8%45.6%101.2%41.8%1.4
Healthcare Median—22.114.218.463.9%-4.4%-33.2%-11.7%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 21 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

GNFT — Frequently Asked Questions

Quick answers to the most common questions about buying GNFT stock.

What is Genfit S.A.'s P/E ratio?

Genfit S.A.'s current P/E ratio is 256.9x. The historical average is 64.0x. This places it at the 100th percentile of its historical range.

What is Genfit S.A.'s EV/EBITDA?

Genfit S.A.'s current EV/EBITDA is 73.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 18.1x.

What is Genfit S.A.'s ROE?

Genfit S.A.'s return on equity (ROE) is 2.2%. The historical average is -52.4%.

Is GNFT stock overvalued?

Based on historical data, Genfit S.A. is trading at a P/E of 256.9x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Genfit S.A.'s profit margins?

Genfit S.A. has 99.6% gross margin and 4.9% operating margin.

How much debt does Genfit S.A. have?

Genfit S.A.'s Debt/EBITDA ratio is 12.4x, indicating high leverage. A ratio above 4x may signal elevated financial risk.